IMMX Stock Price Forecast - 2022, 2030|GlobalFinancialTrends

IMMX Stock Price Forecast – 2022, 2023, 2024, 2025, 2030

21
IMMX Stock Price Forecast – 2022, 2023, 2024, 2025, 2030

IMMX Stock Price Forecast 2022, 2023, 2024, 2025, 2030

Immix Biopharma Inc Shares, +12.28 percent soared 66.0 percent in pre-market trade Monday after the bio-pharmaceutical firm said that its IMX-110 has been designated as a Rare Pediatric Disease (RPD) by the Food and Drug Administration for the treatment of critical illness, such as cancer.  According to the Immix Biopharma Inc, IMX-110 is now being studied in a Phase 1b/2a clinical study. If a New Drug Application (NDA) is certified, the business may be entitled for a Priority Review Voucher (PRV), which can be utilized for marketing approval of any future marketing request.

“We are gratified with the FDA’s recognition of the critical need for a secure and reliable therapy for children with this tragic condition,” stated Immix Biopharma Inc CEO Ilya Rachman. “Our Stage 1b/2a clinical findings in soft tissue sarcoma are encouraging.” The Immix Biopharma Inc Stock Price rise comes as the iShares Biotechnology ETF IBB, -2.68 percent was little moved ahead of the open, while futures ES00, -0.11 percent for the S&P 500 SPX, -0.06 percent rose 0.6 percent.

What Does Immix Biopharma Inc Do?

Immix Biopharma Inc (IMMX), a clinical-stage biopharmaceutical business based in the United States and Australia, is involved in the development of different tissue-specific medicines in cancer and inflammation. Immix Biopharma Inc (IMMX) is working on IMX-110, a soft tissue sarcoma and solid tumor therapy in Stage Ib/IIa clinical studies; IMX-111, a tissue-specific biologic for the therapy of colorectal malignancies; and IMX-120, a tissue-specific bio-pharmaceutical for the treatment of ulcerative colitis and significant Crohn’s disease. Immix Biopharma Inc (IMMX) has a clinical partnership and supply agreement with BeiGene Ltd. for a combined Stage Ib medical study of IMX-110 and anti-PD-1 Tislelizumab in solid malignancies. Immix Biopharma Inc (IMMX) was founded in 2012 and is headquartered in Los Angeles, California.

What Is Immix Biopharma Inc Shares’ Stock Ticker?

What Is Immix Biopharma Inc Shares’ Stock Ticker

Immix Biopharma is a company that lists on the NASDAQ under the stock ticker “IMMX.”

IMMX Stock Price Today

IMMX Stock Price is 6.49 USD, +0.71 (12.28%) today.

14 Days Historical Immix Biopharma Inc Stock Price Data

Date Opening IMMX Stock Price Closing IMMX Stock Price Minimum IMMX Stock Price Maximum IMMX Stock Price
2022-01-04 Open: 7.45 Close: 6.49 Low: 6.01 High: 7.45
2022-01-03 Open: 7.7 Close: 5.78 Low: 5.76 High: 7.92
2021-12-31 Open: 3.4 Close: 3.56 Low: 3.335 High: 3.56
2021-12-30 Open: 3.39 Close: 3.26 Low: 3.26 High: 3.4
2021-12-29 Open: 3.55 Close: 3.32 Low: 3.32 High: 3.605
2021-12-28 Open: 3.165 Close: 3.61 Low: 3.15 High: 3.665
2021-12-27 Open: 3.045 Close: 3.28 Low: 3.01 High: 3.34
2021-12-23 Open: 3.24 Close: 2.95 Low: 2.95 High: 3.24
2021-12-22 Open: 3.51 Close: 3.26 Low: 3.26 High: 3.51
2021-12-21 Open: 3.6 Close: 3.48 Low: 3.27 High: 3.6
2021-12-20 Open: 3.69 Close: 3.25 Low: 3.235 High: 3.69
2021-12-17 Open: 3.99 Close: 4 Low: 3.97 High: 5.14
2021-12-16 Open: 3.67 Close: 3.67 Low: 3.67 High: 3.67

Historical Immix Biopharma Inc Stock Price data:

  • Immix Biopharma Inc Shares’ Market Cap (Previous Close): 46.73 M
  • IMMX Stock Price in USD (Previous Close): 6.490
  • IMMX Shares’ Volume (Previous Close): 62.79 M
  • IMMX Stock Price in USD (Last): 6.490
  • 52 Week High Immix Biopharma Inc Stock Price: 7.920
  • 52 Week Low Immix Biopharma Inc Stock Price: 2.950
  • 45-Day Moving Average of Immix Biopharma Inc (IMMX): 3.976
  • 90-Day Moving Average of Immix Biopharma: 3.976

Immix Biopharma Inc Shares News

Immix Biopharma Inc Shares News

Immix Biopharma Inc (IMMX) was surging on Monday as a result of the US Food and Drug Administration’s Rare Pediatric Disease (RPD) designation.

This RPD classification applies to IMX-110, an experimental medicine being utilized for the treatment of rhabdomyosarcoma. Rhabdomyosarcoma is a potentially fatal kind of pediatric cancer that impacts youngsters.

A Stage 1b/2a clinical study for Immix Biopharma’s cancer therapy is presently underway. With the FDA’s RPD designation, the business can expedite the examination of its therapy. If the FDA accepts IMX-110’s New Drug Application, this might include a Priority Review Voucher.

Ilya Rachman, M.D., PhD., CEO of Immix Biopharma, stated that the FDA announcement sent IMMX shares up on Monday.

The encouraging FDA news for Monday has caused IMMX shares to trade heavily. Over than 81 million shares of the Immix Biopharma Inc’s stock have exchanged as of this writing. This is a significant increase over the daily average transaction volume of 1.2 million Immix Biopharma Inc Shares.

As of Monday morning, IMMX Stock Price was up 118 percent.

Who Are Some of Immix Biopharma Inc’s Key Competitors?

Some companies that are related to Immix Biopharma include APM Human Services International (APM), Asian Citrus (ACHL), CUE Energy Resources (CUE), Graphene NanoChem (GRPH), Inova Resources Limited, (IVA), Mawson Infrastructure Group (MIGID) and Panther Metals (PNT).

When Did Immix Biopharma Inc IPO?

(IMMX) raised $23 million in an initial public offering (IPO) on Thursday, December 16th, 2021. The company issued 4,200,000 shares at $5.00-$6.00 per share.

How Do I Buy IMMX Shares?

APM Human Services International (APM), Inova Resources Limited (IVA), CUE Energy Resources (CUE), Graphene NanoChem (GRPH), Asian Citrus (ACHL), Mawson Infrastructure Group (MIGID), and Panther Metals (PNT) are some firms associated to Immix Biopharma Inc (IMMX).

How Much Money Does Immix Biopharma Inc Do?

The company of IMMX Shares is worth $49.16 million on the market.

IMMX Stock Price Forecast

IMMX Stock Prediction data for the next days

Date IMMX Stock Price Forecast Min IMMX Stock Price Forecast Max IMMX Stock Price Forecast
2022-01-06 Price: 6.152 Min: 4.856 Max: 7.479
2022-01-07 Price: 6.638 Min: 5.375 Max: 7.854
2022-01-10 Price: 7.276 Min: 5.981 Max: 8.486
2022-01-11 Price: 7.250 Min: 6.082 Max: 8.426
2022-01-12 Price: 6.569 Min: 5.357 Max: 7.905
2022-01-13 Price: 6.869 Min: 5.559 Max: 8.194
2022-01-14 Price: 7.355 Min: 6.043 Max: 8.589
2022-01-17 Price: 7.993 Min: 6.735 Max: 9.161
2022-01-18 Price: 7.967 Min: 6.723 Max: 9.243

IMMX Stock Prediction data:

  • IMMX Stock Price is 6.490 USD today.
  • 52 Week High IMMX Stock Prediction: 3.449
  • 52 Week Low IMMX Stock Prediction: 0.000001
  • IMMX Stock Price Forecast’s 45-Day Moving Average: 2.435
  • IMMX Stock Price Forecast’s 90-Day Moving Average: 1.633
  • Based on the IMMX Stock Price Forecast 2022, 2023, 2024, 2025, 2030 data, the future Immix Biopharma Inc Stock Price may decline from 6.490 USD to 0.000001 USD.

Below you will find the IMMX Stock Predictions for the upcoming years.

Date Opening IMMX Stock Price Forecast Closing IMMX Stock Price Forecast Minimum IMMX Stock Prediction Maximum IMMX Stock Prediction Change
IMMX Stock Price Forecast for 2022
February 2022 Open: 2.269 Close: 1.304 Min: 1.304 Max: 2.269 Change: -74.02 %▼
March 2022 Open: 1.268 Close: 0.196 Min: 0.196 Max: 1.268 Change: -547.82 %▼
April 2022 Open: 0.160 Close: 0.000096 Min: 0.0000960 Max: 0.160 Change: -166601.22 %▼
May 2022 Open: 0.000072 Close: 0.000001 Min: 0.000000171 Max: 0.0000720 Change: -41944.97 %▼
June 2022 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000000128 Change: -41944.76 %▼
July 2022 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000001 Change: -31433.68 %▼
August 2022 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000001 Change: -55959.87 %▼
September 2022 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000001 Change: -41944.89 %▼
October 2022 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000001 Change: -31433.62 %▼
November 2022 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000001 Change: -41944.94 %▼
December 2022 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000001 Change: -41944.74 %▼
IMMX Stock Price Forecast for 2023
January 2023 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000001 Change: -41944.86 %▼
February 2023 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000001 Change: -23550.23 %▼
March 2023 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000001 Change: -55959.93 %▼
April 2023 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000001 Change: -23550.27 %▼
May 2023 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000001 Change: -55959.8 %▼
June 2023 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000001 Change: -41962.67 %▼
July 2023 Open: 0.000001 Close: 0.000001 Min: 0.000001 Max: 0.000001 Change: -40099.96 %▼